Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Herrington, DM; Fan, LX; Drum, M; Riley, WA; Pusser, BE; Crouse, JR; Burke, GL; McBurnie, MA; Morgan, TM; Espeland, MA
   Brachial flow-mediated vasodilator responses in population-based research:methods, reproducibility and effects of age, gender and baseline diameter
   JOURNAL OF CARDIOVASCULAR RISK
   
   D.M. Herrington et al., "Brachial flow-mediated vasodilator responses in population-based research:methods, reproducibility and effects of age, gender and baseline diameter", J CARD RISK, 8(5), 2001, pp. 319-328
2. Espeland, MA; Kumanyika, S; Wilson, AC; Wilcox, S; Chao, D; Bahnson, J; Reboussin, DM; Easter, L; Zheng, BY
   Lifestyle interventions influence relative errors in self-reported diet intake of sodium and potassium
   ANNALS OF EPIDEMIOLOGY
   
   M.A. Espeland et al., "Lifestyle interventions influence relative errors in self-reported diet intake of sodium and potassium", ANN EPIDEMI, 11(2), 2001, pp. 85-93
3. Miller, ME; Morgan, TM; Espeland, MA; Emerson, SS
   Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches
   STATISTICS IN MEDICINE
   
   M.E. Miller et al., "Group comparisons involving missing data in clinical trials: a comparison of estimates and power (size) for some simple approaches", STAT MED, 20(16), 2001, pp. 2383-2397
4. Appel, LJ; Espeland, MA; Easter, L; Wilson, AC; Folmar, S; Lacy, CR
   Effects of reduced sodium intake on hypertension control in older individuals - Results from the trial of nonpharmacologic interventions in the elderly (TONE)
   ARCHIVES OF INTERNAL MEDICINE
   
   L.J. Appel et al., "Effects of reduced sodium intake on hypertension control in older individuals - Results from the trial of nonpharmacologic interventions in the elderly (TONE)", ARCH IN MED, 161(5), 2001, pp. 685-693
5. Espeland, MA; Kumanyika, S; Wilson, AC; Reboussin, DM; Easter, L; Self, M; Robertson, J; Brown, WM; McFarlane, M
   Statistical issues in analyzing 24-hour dietary recall and 24-hour urine collection data for sodium and potassium intakes
   AMERICAN JOURNAL OF EPIDEMIOLOGY
   
   M.A. Espeland et al., "Statistical issues in analyzing 24-hour dietary recall and 24-hour urine collection data for sodium and potassium intakes", AM J EPIDEM, 153(10), 2001, pp. 996-1006
6. Barrett-Connor, E; Espeland, MA; Greendale, GA; Trabal, J; Johnson, S; Legault, C; Kritz-Silverstein, D; Einhorn, P
   Postmenopausal hormone use following a 3-year randomized clinical trial
   JOURNAL OF WOMENS HEALTH & GENDER-BASED MEDICINE
   
   E. Barrett-Connor et al., "Postmenopausal hormone use following a 3-year randomized clinical trial", J WOMEN H G, 9(6), 2000, pp. 633-643
7. Chao, DN; Farmer, DF; Sevick, MA; Espeland, MA; Vitolins, M; Naughton, MJ
   The value of session attendance in a weight-loss intervention
   AMERICAN JOURNAL OF HEALTH BEHAVIOR
   
   D.N. Chao et al., "The value of session attendance in a weight-loss intervention", AM J HEAL B, 24(6), 2000, pp. 413-421
8. Chao, D; Espeland, MA; Farmer, D; Register, TC; Lenchik, L; Applegate, WB; Ettinger, WH
   Effect of voluntary weight loss on bone mineral density in older overweight women
   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY
   
   D. Chao et al., "Effect of voluntary weight loss on bone mineral density in older overweight women", J AM GER SO, 48(7), 2000, pp. 753-759
9. Espeland, MA; Whelton, PK; Kostis, JB; Bahnson, JL; Ettinger, WH; Cutler, JA; Appel, LJ; Kumanyika, S; Farmer, D; Elam, J; Wilson, AC; Applegate, WB
   Predictors and mediators of successful long-term withdrawal from antihypertensive medications
   ARCHIVES OF FAMILY MEDICINE
   
   M.A. Espeland et al., "Predictors and mediators of successful long-term withdrawal from antihypertensive medications", ARCH FAM M, 8(3), 1999, pp. 228-236
10. Espeland, MA; Craven, TE; Miller, ME; D'Agostino, R
    1996 Remington Lecture: Modeling multivariate longitudinal data that are incomplete
    ANNALS OF EPIDEMIOLOGY
    
    M.A. Espeland et al., "1996 Remington Lecture: Modeling multivariate longitudinal data that are incomplete", ANN EPIDEMI, 9(3), 1999, pp. 196-205
11. Espeland, MA; Tang, R; Terry, JG; Davis, DH; Mercuri, M; Crouse, JR
    Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery
    STROKE
    
    M.A. Espeland et al., "Associations of risk factors with segment-specific intimal-medial thickness of the extracranial carotid artery", STROKE, 30(5), 1999, pp. 1047-1055
12. Byington, RP; Evans, GW; Espeland, MA; Applegate, WB; Hunninghake, DB; Probstfield, J; Furberg, CD
    Effects of lovastatin and warfarin on early carotid atherosclerosis - Sex-specific analyses
    CIRCULATION
    
    R.P. Byington et al., "Effects of lovastatin and warfarin on early carotid atherosclerosis - Sex-specific analyses", CIRCULATION, 100(3), 1999, pp. E14-E17
13. LEGAULT C; ESPELAND MA; WASILAUSKAS CH; BUSH TL; TRABAL J; JUDD HL; JOHNSON SR; GREENDALE GA
    AGREEMENT IN ASSESSING ENDOMETRIAL PATHOLOGY - THE POSTMENOPAUSAL ESTROGEN PROGESTIN INTERVENTIONS (PEPI) TRIAL/
    Journal of women's health
    
    C. Legault et al., "AGREEMENT IN ASSESSING ENDOMETRIAL PATHOLOGY - THE POSTMENOPAUSAL ESTROGEN PROGESTIN INTERVENTIONS (PEPI) TRIAL/", Journal of women's health, 7(4), 1998, pp. 435-442
14. Shumaker, SA; Reboussin, BA; Espeland, MA; Rapp, SR; McBee, WL; Dailey, M; Bowen, D; Terrell, T; Jones, BN
    The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia
    CONTROLLED CLINICAL TRIALS
    
    S.A. Shumaker et al., "The Women's Health Initiative Memory Study (WHIMS): A trial of the effect of estrogen therapy in preventing and slowing the progression of dementia", CONTR CL TR, 19(6), 1998, pp. 604-621
15. ESPELAND MA; HOGAN PE; FINEBERG SE; HOWARD G; SCHROTT H; WACLAWIW MA; BUSH TL
    EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON GLUCOSE AND INSULIN CONCENTRATIONS
    Diabetes care
    
    M.A. Espeland et al., "EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON GLUCOSE AND INSULIN CONCENTRATIONS", Diabetes care, 21(10), 1998, pp. 1589-1595
16. WHELTON PK; APPEL LJ; ESPELAND MA; APPLEGATE WB; ETTINGER WH; KOSTIS JB; KUMANYIKA S; LACY CR; JOHNSON KC; FOLMAR S; CUTLER JA
    SODIUM REDUCTION AND WEIGHT-LOSS IN THE TREATMENT OF HYPERTENSION IN OLDER PERSONS - A RANDOMIZED CONTROLLED TRIAL OF NONPHARMACOLOGIC INTERVENTIONS IN THE ELDERLY (TONE)
    JAMA, the journal of the American Medical Association
    
    P.K. Whelton et al., "SODIUM REDUCTION AND WEIGHT-LOSS IN THE TREATMENT OF HYPERTENSION IN OLDER PERSONS - A RANDOMIZED CONTROLLED TRIAL OF NONPHARMACOLOGIC INTERVENTIONS IN THE ELDERLY (TONE)", JAMA, the journal of the American Medical Association, 279(11), 1998, pp. 839-846
17. TERRY JG; TANG R; DAVIS DH; ESPELAND MA; MERCURI M; BOND G; CROUSE JR
    ASSOCIATIONS OF ARTERIAL DIMENSIONS AND ATHEROSCLEROSIS OF THE BRACHIAL AND CAROTID ARTERIES ARE THE SAME IN CORONARY-ARTERY DISEASE CASES AND CONTROLS
    Circulation
    
    J.G. Terry et al., "ASSOCIATIONS OF ARTERIAL DIMENSIONS AND ATHEROSCLEROSIS OF THE BRACHIAL AND CAROTID ARTERIES ARE THE SAME IN CORONARY-ARTERY DISEASE CASES AND CONTROLS", Circulation, 97(8), 1998, pp. 58-58
18. ESPELAND MA; HOGAN PE; BUSH TL; HOWARD G
    EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON CARBOHYDRATE-METABOLISM
    Circulation
    
    M.A. Espeland et al., "EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON CARBOHYDRATE-METABOLISM", Circulation, 97(8), 1998, pp. 74-74
19. ESPELAND MA; MARCOVINA SM; MILLER V; WOOD PD; WASILAUSKAS C; SHERWIN R; SCHROTT H; BUSH TL
    EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON LIPOPROTEIN(A) CONCENTRATION
    Circulation
    
    M.A. Espeland et al., "EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON LIPOPROTEIN(A) CONCENTRATION", Circulation, 97(10), 1998, pp. 979-986
20. Kostis, JB; Espeland, MA; Appel, L; Johnson, KC; Pierce, J; Wofford, JL
    Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?
    AMERICAN JOURNAL OF CARDIOLOGY
    
    J.B. Kostis et al., "Does withdrawal of antihypertensive medication increase the risk of cardiovascular events?", AM J CARD, 82(12), 1998, pp. 1501-1508
21. Espeland, MA
    Cardioprotective effects of postmenopausal hormone treatment
    AMERICAN JOURNAL OF CARDIOLOGY
    
    M.A. Espeland, "Cardioprotective effects of postmenopausal hormone treatment", AM J CARD, 82(10A), 1998, pp. 37S-39S
22. Espeland, MA
    Cardioprotective effects of postmenopausal hormone treatment - Questions and answers
    AMERICAN JOURNAL OF CARDIOLOGY
    
    M.A. Espeland, "Cardioprotective effects of postmenopausal hormone treatment - Questions and answers", AM J CARD, 82(10A), 1998, pp. 39S-39S
23. LANGER RD; PIERCE JJ; OHANLAN KA; JOHNSON SR; ESPELAND MA; TRABAL JF; BARNABEI VM; MERINO MJ; SCULLY RE
    TRANSVAGINAL ULTRASONOGRAPHY COMPARED WITH ENDOMETRIAL BIOPSY FOR THEDETECTION OF ENDOMETRIAL DISEASE
    The New England journal of medicine
    
    R.D. Langer et al., "TRANSVAGINAL ULTRASONOGRAPHY COMPARED WITH ENDOMETRIAL BIOPSY FOR THEDETECTION OF ENDOMETRIAL DISEASE", The New England journal of medicine, 337(25), 1997, pp. 1792-1798
24. ESPELAND MA; STEFANICK ML; KRITZSILVERSTEIN D; FINEBERG SE; WACLAWIW MA; JAMES MK; GREENDALE GA
    EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON BODY-WEIGHT AND WAIST ANDHIP GIRTHS
    The Journal of clinical endocrinology and metabolism
    
    M.A. Espeland et al., "EFFECT OF POSTMENOPAUSAL HORMONE-THERAPY ON BODY-WEIGHT AND WAIST ANDHIP GIRTHS", The Journal of clinical endocrinology and metabolism, 82(5), 1997, pp. 1549-1556
25. GREENDALE GA; JAMES MK; ESPELAND MA; BARRETTCONNOR E
    CAN WE MEASURE PRIOR POSTMENOPAUSAL ESTROGEN PROGESTIN USE - THE POSTMENOPAUSAL ESTROGEN/PROGESTIN INTERVENTIONS TRIAL/
    American journal of epidemiology
    
    G.A. Greendale et al., "CAN WE MEASURE PRIOR POSTMENOPAUSAL ESTROGEN PROGESTIN USE - THE POSTMENOPAUSAL ESTROGEN/PROGESTIN INTERVENTIONS TRIAL/", American journal of epidemiology, 146(9), 1997, pp. 763-770
26. WHELTON PK; BAHNSON J; APPEL LJ; CHARLESTON J; COSGROVE N; ESPELAND MA; FOLMAR S; HOAGLAND D; KREIGER S; LACY C; LICHTERMANN L; OATESWILLIAMS F; TAYBACK M; WILSON AC
    RECRUITMENT IN THE TRIAL OF NONPHARMACOLOGIC INTERVENTION IN THE ELDERLY (TONE)
    Journal of the American Geriatrics Society
    
    P.K. Whelton et al., "RECRUITMENT IN THE TRIAL OF NONPHARMACOLOGIC INTERVENTION IN THE ELDERLY (TONE)", Journal of the American Geriatrics Society, 45(2), 1997, pp. 185-193
27. MILLER ME; JAMES MK; LANGEFELD CD; ESPELAND MA; FREEDMAN JA; MARTIN DK; SMITH DM
    SOME TECHNIQUES FOR THE ANALYSIS OF WORK SAMPLING DATA
    Statistics in medicine
    
    M.E. Miller et al., "SOME TECHNIQUES FOR THE ANALYSIS OF WORK SAMPLING DATA", Statistics in medicine, 15(6), 1996, pp. 607-618
28. DOLECEK TA; BRADHAM KH; ESPELAND MA; MARGITIC SE; BYINGTON RP; HOEN H; KAPPELLE LJ
    MAXIMIZING RECRUITMENT EFFORTS IN A DRUG LIPID-LOWERING TRIAL WITH DIETARY INTERVENTION TO LOWER LDL CHOLESTEROL
    Controlled clinical trials
    
    T.A. Dolecek et al., "MAXIMIZING RECRUITMENT EFFORTS IN A DRUG LIPID-LOWERING TRIAL WITH DIETARY INTERVENTION TO LOWER LDL CHOLESTEROL", Controlled clinical trials, 17(1), 1996, pp. 33-45
29. BARRETTCONNOR E; SCHROTT HG; GREENDALE G; KRITZSILVERSTEIN D; ESPELAND MA; STERN MP; BUSH T; PERLMAN JA
    FACTORS ASSOCIATED WITH GLUCOSE AND INSULIN LEVELS IN WEALTHY POSTMENOPAUSAL WOMEN
    Diabetes care
    
    E. Barrettconnor et al., "FACTORS ASSOCIATED WITH GLUCOSE AND INSULIN LEVELS IN WEALTHY POSTMENOPAUSAL WOMEN", Diabetes care, 19(4), 1996, pp. 333-340
30. ESPELAND MA; CRAVEN TE; RILEY WA; CORSON J; ROMONT A; FURBERG CD
    RELIABILITY OF LONGITUDINAL ULTRASONOGRAPHIC MEASUREMENTS OF CAROTID INTIMAL-MEDIAL THICKNESSES
    Stroke
    
    M.A. Espeland et al., "RELIABILITY OF LONGITUDINAL ULTRASONOGRAPHIC MEASUREMENTS OF CAROTID INTIMAL-MEDIAL THICKNESSES", Stroke, 27(3), 1996, pp. 480-485
31. ESPELAND MA; KUMANYIKA S; KOSTIS JB; ALGIRE J; APPLEGATE WB; ETTINGER W; WHELTON PK; BAHNSON J
    ANTIHYPERTENSIVE MEDICATION USE AMONG RECRUITS FOR THE TRIAL OF NONPHARMACOLOGIC INTERVENTIONS IN THE ELDERLY (TONE)
    Journal of the American Geriatrics Society
    
    M.A. Espeland et al., "ANTIHYPERTENSIVE MEDICATION USE AMONG RECRUITS FOR THE TRIAL OF NONPHARMACOLOGIC INTERVENTIONS IN THE ELDERLY (TONE)", Journal of the American Geriatrics Society, 44(10), 1996, pp. 1183-1189
32. BUSH TL; ESPELAND MA; MEBANESIMS I
    THE POSTMENOPAUSAL ESTROGEN PROGESTIN INTERVENTIONS (PEPI) TRIAL - OVERVIEW
    Controlled clinical trials
    
    T.L. Bush et al., "THE POSTMENOPAUSAL ESTROGEN PROGESTIN INTERVENTIONS (PEPI) TRIAL - OVERVIEW", Controlled clinical trials, 16(4), 1995, pp. 1-2
33. ESPELAND MA; BUSH TL; MEBANESIMS I; STEFANICK ML; JOHNSON S; SHERWIN R; WACLAWIW M
    RATIONALE, DESIGN, AND CONDUCT OF THE PEPI TRIAL
    Controlled clinical trials
    
    M.A. Espeland et al., "RATIONALE, DESIGN, AND CONDUCT OF THE PEPI TRIAL", Controlled clinical trials, 16(4), 1995, pp. 3-19
34. MILLER VT; BYINGTON RL; ESPELAND MA; LANGER R; MARCUS R; SHUMAKER S; STERN MP
    BASE-LINE CHARACTERISTICS OF THE PEPI PARTICIPANTS
    Controlled clinical trials
    
    V.T. Miller et al., "BASE-LINE CHARACTERISTICS OF THE PEPI PARTICIPANTS", Controlled clinical trials, 16(4), 1995, pp. 54-65
35. SHERERTZ RJ; CARRUTH WA; MAROSOK RD; ESPELAND MA; JOHNSON RA; SOLOMON DD
    CONTRIBUTION OF VASCULAR CATHETER MATERIAL TO THE PATHOGENESIS OF INFECTION - THE ENHANCED RISK OF SILICONE IN-VIVO
    Journal of biomedical materials research
    
    R.J. Sherertz et al., "CONTRIBUTION OF VASCULAR CATHETER MATERIAL TO THE PATHOGENESIS OF INFECTION - THE ENHANCED RISK OF SILICONE IN-VIVO", Journal of biomedical materials research, 29(5), 1995, pp. 635-645
36. ESPELAND MA; APPLEGATE W; FURBERG CD; LEFKOWITZ D; RICE L; HUNNINGHAKE D
    ESTROGEN REPLACEMENT THERAPY AND PROGRESSION OF INTIMAL-MEDIAL THICKNESS IN THE CAROTID ARTERIES OF POSTMENOPAUSAL WOMEN
    American journal of epidemiology
    
    M.A. Espeland et al., "ESTROGEN REPLACEMENT THERAPY AND PROGRESSION OF INTIMAL-MEDIAL THICKNESS IN THE CAROTID ARTERIES OF POSTMENOPAUSAL WOMEN", American journal of epidemiology, 142(10), 1995, pp. 1011-1019
37. PROBSTFIELD JL; MARGITIC SE; BYINGTON RP; ESPELAND MA; FURBERG CD
    RESULTS OF THE PRIMARY OUTCOME MEASURE AND CLINICAL EVENTS FROM THE ASYMPTOMATIC CAROTID-ARTERY PROGRESSION STUDY
    The American journal of cardiology
    
    J.L. Probstfield et al., "RESULTS OF THE PRIMARY OUTCOME MEASURE AND CLINICAL EVENTS FROM THE ASYMPTOMATIC CAROTID-ARTERY PROGRESSION STUDY", The American journal of cardiology, 76(9), 1995, pp. 47-53
38. BYINGTON RP; FURBERG CD; CROUSE JR; ESPELAND MA; BOND MG
    PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II)
    The American journal of cardiology
    
    R.P. Byington et al., "PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II)", The American journal of cardiology, 76(9), 1995, pp. 54-59
39. CROUSE JR; BYINGTON RP; BOND MG; ESPELAND MA; CRAVEN TE; SPRINKLE JW; MCGOVERN ME; FURBERG CD
    PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II)
    The American journal of cardiology
    
    J.R. Crouse et al., "PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (PLAC-II)", The American journal of cardiology, 75(7), 1995, pp. 455-459
40. CROUSE JR; BYINGTON RP; BOND MG; ESPELAND MA; CRAVEN TE; SPRINKLE JW; MCGOVERN ME; FURBERG CD
    PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (VOL75, PG 455, 1995)
    The American journal of cardiology
    
    J.R. Crouse et al., "PRAVASTATIN, LIPIDS, AND ATHEROSCLEROSIS IN THE CAROTID ARTERIES (VOL75, PG 455, 1995)", The American journal of cardiology, 75(12), 1995, pp. 862-862
41. ESPELAND MA; HOEN H; BYINGTON R; HOWARD G; RILEY WA; FURBERG CD
    SPATIAL-DISTRIBUTION OF CAROTID INTIMAL-MEDIAL THICKNESS AS MEASURED BY B-MODE ULTRASONOGRAPHY
    Stroke
    
    M.A. Espeland et al., "SPATIAL-DISTRIBUTION OF CAROTID INTIMAL-MEDIAL THICKNESS AS MEASURED BY B-MODE ULTRASONOGRAPHY", Stroke, 25(9), 1994, pp. 1812-1819
42. SMITH SL; COLENDA CC; ESPELAND MA
    FACTORS DETERMINING THE LEVEL OF ANXIETY STATE IN GERIATRIC PRIMARY-CARE PATIENTS IN A COMMUNITY-DWELLING
    Psychosomatics
    
    S.L. Smith et al., "FACTORS DETERMINING THE LEVEL OF ANXIETY STATE IN GERIATRIC PRIMARY-CARE PATIENTS IN A COMMUNITY-DWELLING", Psychosomatics, 35(1), 1994, pp. 50-58
43. ESPELAND MA; APPLEGATE WB; HUNNINGHAKE D; LEFKOWITZ D; RIICE L; FURBERG CD
    HORMONE REPLACEMENT THERAPY AND PROGRESSION OF INTIMAL-MEDIAL THICKNESS IN THE CAROTID ARTERIES IN POSTMENOPAUSAL WOMEN
    Circulation
    
    M.A. Espeland et al., "HORMONE REPLACEMENT THERAPY AND PROGRESSION OF INTIMAL-MEDIAL THICKNESS IN THE CAROTID ARTERIES IN POSTMENOPAUSAL WOMEN", Circulation, 90(4), 1994, pp. 128-128
44. ESPELAND MA; APPLEGATE WB; HUNNINGHAKE D; LEFKOWITZ D; RIICE L; FURBERG CD
    HORMONE REPLACEMENT THERAPY AND PROGRESSION OF INTIMAL-MEDIAL THICKNESS IN THE CAROTID ARTERIES IN POSTMENOPAUSAL WOMEN
    Circulation
    
    M.A. Espeland et al., "HORMONE REPLACEMENT THERAPY AND PROGRESSION OF INTIMAL-MEDIAL THICKNESS IN THE CAROTID ARTERIES IN POSTMENOPAUSAL WOMEN", Circulation, 90(4), 1994, pp. 128-128
45. FURBERG CD; ADAMS HP; APPLEGATE WB; BYINGTON RP; ESPELAND MA; HARTWELL T; HUNNINGHAKE DB; LEFKOWITZ DS; PROBSTFIELD J; RILEY WA; YOUNG B
    EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS
    Circulation
    
    C.D. Furberg et al., "EFFECT OF LOVASTATIN ON EARLY CAROTID ATHEROSCLEROSIS AND CARDIOVASCULAR EVENTS", Circulation, 90(4), 1994, pp. 1679-1687
46. MUNDORFFSHRESTHA SA; FEATHERSTONE JDB; EISENBERG AD; COWLES E; CURZON MEJ; ESPELAND MA; SHIELDS CP
    CARIOGENIC POTENTIAL OF FOODS .2. RELATIONSHIP OF FOOD COMPOSITION, PLAQUE MICROBIAL COUNTS, AND SALIVARY PARAMETERS TO CARIES IN THE RAT MODEL
    Caries research
    
    S.A. Mundorffshrestha et al., "CARIOGENIC POTENTIAL OF FOODS .2. RELATIONSHIP OF FOOD COMPOSITION, PLAQUE MICROBIAL COUNTS, AND SALIVARY PARAMETERS TO CARIES IN THE RAT MODEL", Caries research, 28(2), 1994, pp. 106-115
47. FURBERG CD; BYINGTON RP; CROUSE JR; ESPELAND MA
    PRAVASTATIN, LIPIDS, AND MAJOR CORONARY EVENTS
    The American journal of cardiology
    
    C.D. Furberg et al., "PRAVASTATIN, LIPIDS, AND MAJOR CORONARY EVENTS", The American journal of cardiology, 73(15), 1994, pp. 1133-1134
48. FREEDMAN BI; SPRAY BJ; HEISE ER; ESPELAND MA; CANZANELLO VJ
    A RACE-CONTROLLED HUMAN-LEUKOCYTE ANTIGEN FREQUENCY-ANALYSIS IN LUPUSNEPHRITIS
    American journal of kidney diseases
    
    B.I. Freedman et al., "A RACE-CONTROLLED HUMAN-LEUKOCYTE ANTIGEN FREQUENCY-ANALYSIS IN LUPUSNEPHRITIS", American journal of kidney diseases, 21(4), 1993, pp. 378-382
49. ESPELAND MA; RUSHING JT; DEVAULT A
    ESTIMATING INCIDENCE AND DIAGNOSTIC ERROR RATES FOR BIVARIATE PROGRESSIVE PROCESSES
    Biometrics
    
    M.A. Espeland et al., "ESTIMATING INCIDENCE AND DIAGNOSTIC ERROR RATES FOR BIVARIATE PROGRESSIVE PROCESSES", Biometrics, 49(4), 1993, pp. 1010-1021